RAYMOND JAMES & ASSOCIATES - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 62 filers reported holding SURFACE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q4 2021$88,000
-84.5%
18,393
-75.4%
0.00%
-100.0%
Q3 2021$567,000
-28.4%
74,898
-29.5%
0.00%0.0%
Q2 2021$792,000
+3.1%
106,203
+7.8%
0.00%0.0%
Q1 2021$768,000
+97.9%
98,511
+134.3%
0.00%
Q4 2020$388,000
-36.1%
42,037
-52.3%
0.00%
-100.0%
Q3 2020$607,00088,0390.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders